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Available online 20 February 2008The carboxyl tail of G protein-coupled receptors contains motifs that regulate receptor interactions with
intracellular partners. Activation of the human neutrophil complement fragment C5a receptor (C5aR) is
terminated by phosphorylation of the carboxyl tail followed by receptor internalization. In this study, we
demonstrated that bulky hydrophobic residues in the membrane-proximal region of the C5aR carboxyl tail
play an important role in proper structure and function of the receptor: Substitution of leucine 319 with
alanine (L319A) resulted in receptor retention in the endoplasmic reticulum, whereas a L318A substitution
allowed receptor transport to the cell surface, but showed slow internalization upon activation, presumably
due to a defect in phosphorylation by both PKC and GRK. Normal agonist-induced activation of ERK1/2 and
intracellular calcium release suggested that the L318A mutation did not affect receptor signaling. Binding of
GRK2 and PKCβII to intracellular loop 3 of C5aR in vitro indicated that mutagenesis of L318 did not affect
kinase binding. Limited proteolysis with trypsin revealed a conformational difference between wild type
and mutant receptor. Our studies support a model in which the L318/L319 stabilizes an amphipathic helix
(Q305–R320) in the membrane-proximal region of C5aR.
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Cytoplasmic helix 81. Introduction
Neutrophil activationwith the complement fragment C5a is involved
in the regulation of numerous immunological processes, including host
defense and inﬂammation [1]. The C5a receptor (C5aR) is a classical
chemoattractant receptor that is primarily expressed in neutrophils. C5a
binding to C5aR initiates a signal transduction cascade, which results in
cell activation and movement from circulation into the tissue along the
gradient of agonist.
C5aR belongs to a family of seven transmembrane helix G protein-
coupled receptors (GPCRs) and preferentially activates members of
the Gi family of heterotrimeric G proteins. Binding of agonist initiates
conformational changes in the receptor such that the receptor can
interact with and activate speciﬁc heterotrimeric G proteins. Activated
G proteins stimulate or inhibit speciﬁc effector proteins, which even-
tually result in specialized functional outcomes. Receptor phosphor-
ylation is an important physiological mechanism that protects cells
against harmful overstimulation. Activated C5aR undergoes phos-
phorylation by both PKC, a second messenger activated kinase, and byMontana State University, 109
014; fax: +1 406 994 4926.
).
in-coupled receptor; GRK, G
r signal-regulated kinase 1/2;
; AR, adrenergic receptor
l rights reserved.G protein-coupled receptor kinases (GRKs) [1]. Seven members of
three GRK subfamilies are known to date. They display different tissue
distribution, physical properties and substrate speciﬁcity for GPCRs
(for review, see [2]). For instance, GRK2 and 6 are expressed at high
levels in immune cells including neutrophils [3]. The role of GRK2
in C5aR phosphorylation is inconclusive: Overexpression of GRK2 in
COS cells enhanced phosphorylation of C5aR [4], while no transloca-
tion of GRK2 was detected to membranes of C5a-activated leukocytes
[5].
Internalization and trafﬁcking of the receptor through the endo-
somal system are regulated by many interactions providing speciﬁcity
for protein targeting. Endocytosed receptors accumulate initially in
the early (sorting) endosomes from which they are targeted to lyso-
somes for degradation or transported back to the cell surface, either
directly or via a recycling compartment. Numerous studies of GPCR
endocytosis have described multiple internalization signals as well as
cognate interactive partners that determine the ﬁnal destination of
the receptor. Many of the signals consist of short linear amino acid
sequences that were classiﬁed as tyrosine or di-leucine based motifs
[6]. In addition to classical di-leucine motifs that require the presence
of acidic residues upstream of di-leucine ([D/E] X2–3 L [L/I]), a few
unconventional di-leucine signals have been involved in protein
endocytosis. Some of them have one or several serines that become
phosphorylated upstream of di-leucine [7]. Classical di-leucine motifs
are usually part of nonstructured loops, while a serine-dependent
motif is likely to adopt a coil structure [8].
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in CHO cells and neutrophils [9]. We found that ligand activation
resulted in degradation of a signiﬁcant percentage of the receptor
during each round of internalization. A search of the amino acid
sequence of the putative intracellular domains of C5aR did not reveal
any classical tyrosine or di-leucine based motifs for internalization.
Nevertheless, C5aR contains di-leucine in the membrane-proximal
region of the carboxyl tail that is accompanied by phosphogroup
acceptors, S317 and S314, at −1 and −4 positions. We decided to
examine the role of the di-leucine L318/L319 in C5aR internalization.
2. Materials and methods
2.1. Reagents and antibodies
Human recombinant C5a was purchased from Sigma-Aldrich (St. Louis, MO) or
Biovision Research Products (Mountain View, CA). 125I-labeled recombinant C5a was
from Perkin Elmer (Boston, MA). Trypsin Gold, Mass spectrometry grade was obtained
from Promega Corporation (Madison, WI). Pertussis toxin was purchased from Sigma-
Aldrich (St. Louis, MO). Endoglycosidase H was obtained from New England Biolabs Inc.
(Ipswich, MA). Afﬁnity puriﬁed rabbit polyclonal anti-GRK2 (c-15), anti-RhoA (119), and
mouse monoclonal anti-Arf6 (3A-1) antibodies were purchased from Santa Cruz Bio-
technology Inc. (Santa Cruz, CA). Rabbit polyclonal anti-phospho-PKC (pan) (βIISer660)
and rabbit monoclonal anti-phospho-p44/42 MAPK (Thr202/Tyr204) (197G2) anti-
bodies were obtained from Cell Signaling Technology Inc. (Danvers, MA). Rabbit poly-
clonal anti-p44/42 MAPK antibody was from Upstate Cell Signaling Solutions (Lake
Placid, NY). The polyclonal anti-C5aR serum [9] raised against the C-terminal 12 amino
acids of the receptor was afﬁnity puriﬁed using recombinant GST-C5aR carboxyl tail as
an antigen. Monoclonal antibody 32-G1 against C5aR phosphorylated on Ser-334 was
described previously [10]. Horseradish-peroxidase-conjugated goat anti-mouse and
anti-rabbit antibodies were purchased from Jackson ImmunoResearch Laboratories Inc.
(West Grove, PA). Alexa™488-conjugated goat anti-rabbit antibody was obtained from
Molecular Probes Inc. (Eugene, OR).
2.2. Oligonucleotide-directed mutagenesis of C5aR and CHO cell transfection
Point mutations of human C5aR were generated by oligonucleotide-directed
mutagenesis using single-stranded DNA template and conﬁrmed by DNA sequencing
(Nevada Genomics Center, University of Nevada — Reno). cDNA with mutation was
inserted into pBGSA expression vector [11]. Constructs were transfected into Chinese
hamster ovary (CHO) cells using Lipofectamine™2000 transfection reagent (Invitrogen
Life Technologies) according to the manufacturer's recommendations. CHO cells were
cultured in α-modiﬁed Eagle's medium (α-MEM; Sigma) supplemented with 5% fetal
bovine serum (FBS), 50 U/ml penicillin and 50 μg/ml streptomycin. Stable transfectantsFig. 1. Exchange of L319 to alanine resulted in retention of C5aR in the ER. A) Immunoﬂuores
L319A. Immunostaining with anti-C5aR antibody showed plasma membrane localization of
four different clones for each mutant receptor. B) Analysis of susceptibility of wild type C5aR
wild type or mutant C5aR were denatured for 10min at 60 °C and treated with Endo H accord
and Endo H treated (+) membranes were separated in 10% SDS-polyacrylamide gel and anal
ER-glycosylated and non-glycosylated forms of C5aR. One representative image is shown.were selectedwith 0.5mg/ml of G-418. Twelve to sixteen single colonies were tested for
C5aR expression and cellular localization by immunoﬂuorescence microscopy. A few
clones with expression levels similar to the wild type receptor were chosen for further
study. Wild type C5aR and C5aR L318A mutant showed similar binding afﬁnity for 125I-
C5a (Perkin Elmer).
2.3. Indirect immunoﬂuorescence microscopy
CHO cells expressing C5aRs were grown on a glass cover slip. After the experiment,
cells were rinsed with PBS, ﬁxed with 2.5% paraformaldehyde (PFA) in phosphate-
buffered saline (PBS) for 1 h and permeabilized with 0.01% saponin in PBS/0.2% gelatin
solution. Antibody labeling was performed with rabbit anti-C5aR diluted in PBS/
saponin/gelatin solution. Secondary Alexa™488-conjugated goat anti-rabbit antibody
was used at 1:1000 dilution. The coverslips were mounted in 2.5 mg/ml DABCO/
Glycergel (Sigma) and viewed using a 63× objective ﬁtted to an Axioskop 2 plus
microscope (Carl Zeiss Inc., Thornwood, NY). The digital images were cropped,
assembled, and labeled in Adobe Photoshop.
2.4. Ca2+ mobilization assay
CHO cells expressing C5aRs were induced overnight with 6 mM Na butyrate, then
incubated with 1 mM EDTA, pH 8.0 in Ca2+/Mg2+-free PBS to remove cells from plates.
Release of intracellular Ca2+ in response to C5a or ATP stimulation was detected using
ﬂuorescent marker Fura 2-AM (Molecular Probes) as previously described [12]. To
determine EC50 values, the relative amount of C5a-induced calcium release was
calculated by subtracting the base line from the C5a peak value. Data were analyzed
by non-linear regression analysis using Prism 3.0 software (GraphPad Software,
San Diego, CA).
2.5. ERK1/2 activation assay
CHO cells expressing C5aRs were induced overnight with 6 mM Na butyrate and
pre-incubated in serum-free medium for 4 h to reduce background ERK1/2 activation
caused by growth factors in the serum. Cells were stimulated with C5a in a time- or
dose-dependent manner, rinsed with cold PBS and collected in Laemmli sample buffer
[13]. Cell lysates were analyzed in western blots using rabbit anti-ERK1/2 and anti-
phospho-ERK1/2 antibodies.
2.6. Radioligand internalization assay
Monolayers of CHO cells expressing C5aR or C5aR L318A were stimulated for 3, 10
and 30 min with 100 nM C5a and 125I-C5a (Perkin Elmer, Boston, MA) at a 100:1 ratio.
After incubation cells were rinsed with cold PBS. To remove a surface bound ligand half
of the dishes representing each time point were rinsed with acidic PBS pH 2.8. Cells
were lysed in 1% Triton X-100, collected with cotton swabs and counted in the Apex™
Series 10/200 Plus gamma-counter (ICN Biomedical Inc., Irvine, CA). Non-speciﬁccence microscopy of stably transfected CHO cells expressing either C5aR L318A or C5aR
C5aR L318A and intracellular retention of C5aR L319A. The images are representative of
and di-leucine mutants to Endo H treatment. Membranes of CHO cells expressing either
ing to the manufacturer's recommendations (New England Biolabs Inc.). Non-treated (−)
yzed by western blotting using anti-C5aR antibody. Arrows indicate Golgi-glycosylated,
Fig. 2. Internalization of C5aR L318A occurs at a reduced rate. A) Stable CHO
transfectants were incubated for 3 h with or without 100 nM C5a. To accumulate
internalized receptor, cells were incubated with ligand and 50 mM NH4Cl. Receptors
were visualized using rabbit anti-C5aR antibody. Representative images of two inde-
pendent experiments are shown. Bar 50 μm. B) CHO transfectants were incubated at
37 °C with 125I-C5a for the indicated times. Surface bound ligand was removed by
washing cells with cold PBS, pH 2.8. Internalization was calculated as the percentage of
the acid resistant radioactivity out of total cell-associated radioactivity. Results are
mean±S.D. of three independent experiments (⁎pb0.05; ⁎⁎pb0.01).
Fig. 3. C5aR L318A becomes dephosphorylated at a slower rate than wild type C5aR.
Cells were incubated for 10 min at 37 °C with 50 nM C5a followed by a 0, 30, 60 or
120 min chase in warm medium containing 1 mM cycloheximide (to inhibit protein
synthesis). Wild type C5aR reached complete dephosphorylation after 60 min, whereas
C5aR L318A remained partly phosphorylated up to 120 min.
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uptake was quantiﬁed essentially as previously described by Pollok-Kopp et al. [10].
2.7. Pulse–chase dephosphorylation assay
Stably transfected CHO cells were placed in fresh complete medium for 15 min, and
then stimulated with 50 nM C5a for 10 min (pulse). Cells were rinsed twice with cold
PBS to remove ligand. After adjustment to original incubation conditions with warm
complete medium, cells were further incubated for indicated times (chase). For a chase
time longer than 1 h, 1 mM cycloheximide was included in the medium to prevent
synthesis of new proteins. After the experiment, cells were brieﬂy washed with ice-cold
PBS, collected in PBS with protease inhibitor cocktail III (Calbiochem) and sonicated
brieﬂy. The total membranes were collected by centrifugation at 21,000 ×g for 20 min
and solubilized in Laemmli sample buffer.
2.8. Western blotting
Protein samples were lysed in Laemmli sample buffer, heated at 60 °C for 15 min,
separated on 8% or 10% SDS-polyacrylamide gel, and transferred to a 0.45 μM nitro-
cellulose membrane using a semi-wet unit (Bio-Rad). To conﬁrm equal loading and
efﬁcient transfer, the membrane was brieﬂy stained in a water-soluble protein dye, 0.1%Ponceau S in 3% glacial acetic acid. The membrane was blocked in 10% non-fat dry milk
in Tris buffered salinewith 0.5% Tween-20 (TBST) for at least 1 h. After extensivewashes
with PBS, the membrane was incubated with a primary antibody for 1 h at room
temperature or overnight at 4 °C. Primary antibodies were diluted in TBSTcontaining 5%
BSA. The following dilutions were used: rabbit anti-C5aR, 1:1000; anti-ERK1/2, 1:4000;
anti-phospho-ERK1/2, 1:1000; anti-GRK2, 1:200; anti-phospho-PKCβII, 1:1000; anti-
RhoA, 1:1000; mouse 32-G1, 40 μg/ml; and anti-Arf6, 1:500.
2.9. Recombinant protein design, expression and in vitro binding assay
Three constructs, GST-C5aR il1 (T62–W74), GST-C5aR il2 (R134–L152) and GST-
C5aR il3 (I225–L241) were obtained by annealing multiple oligonucleotides. Wild type
and mutant cytoplasmic tails (N296–V350) were ampliﬁed by PCR and cloned into
pGEM T-easy vector (Promega) followed by sub-cloning into pGEX T4-1 expression
vector (Amersham Biosciences). The integrity of all constructs was veriﬁed by
nucleotide sequencing (Nevada Genomics Center, Reno, NV). Recombinant proteins
were expressed in E. coli and afﬁnity puriﬁed according to the manufacturer's protocol
(Amersham Biosciences). Due to the relatively high content of hydrophobic residues in
the intracellular domains of C5aR, cells expressing GST-tagged proteins were induced
with 100 μM IPTG for 16 h at low temperature (18 °C). Initial lysis was performed in the
buffer containing 1% Triton X-100.
For in vitro binding assay, 25 μg of GST fusion protein was mixed with 150 μl of
neutrophil cytosol (an equivalent of 108 cells/ml) in binding buffer (100mM Tris, pH 7.0,
1% octylglucoside, 10% sorbitol, 100 mM NaCl, 1 mM EDTA and protease inhibitor
cocktail). Binding was allowed for 4–5 h at 4 °C with rotation. BSA-blocked Glutathione-
Sepharose beads (15 μl) were added for an additional 30 min incubation. Beads were
washed twice with binding buffer. Complexes were eluted with 20 mM reduced glu-
tathione (pH 7.4), mixed with Laemmli sample buffer and separated on 10% SDS-
polyacrylamide gel. Interacting proteinswere detected bywestern blotting, as described
above.
2.10. Preparation of neutrophil cytosol
Neutrophils were puriﬁed by gelatin sedimentation from human venous blood of
healthy donors. Cell activation and lysis were performed as previously described [14].
Cytosol was frozen in aliquots at −70 °C.
2.11. Limited proteolysis with trypsin
CHO cells expressing C5aR or C5aR L318A were collected in PBS with protease
inhibitor cocktail. After a brief sonication, membranes were sedimented at 21,000 ×g for
20 min at 4 °C and then solubilized with 1% Triton X-100 in sterile PBS on ice for 1 h.
Clariﬁed membrane extract was used in the experiments. Trypsin stock solution and
dilutions were made according to the manufacturer's recommendation (Promega). To
select a trypsin dilution, CHO membranes were treated with increasing concentrations
of trypsin for 1 h at room temperature. Proteolysis was stopped by placing samples on
ice for 10 min, adding Laemmli sample buffer and heating at 60 °C for 5 min. A time-
course digest was performed on duplicate membrane aliquots using 1.25 μg/ml trypsin.
C5aR proteolysis was detected by western blotting using anti-C5aR antibody.
3. Results
3.1. Mutation of L319 results in retention of C5aR in the endoplasmic
reticulum
We have previously demonstrated that about 50% of C5aR under-
goes degradation during 3 h of continuous agonist stimulation, both in
neutrophils and stably transfected CHO cells [9]. Based on pulse–
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determine that about 60–70% of the receptor recycled back to the cell
surface [9]. To determine whether di-leucine (L318/L319) located in
the membrane-proximal region of the C5aR cytoplasmic tail is part of
an internalization motif, we generated single and double leucine to
alanine mutations and expressed the mutants in CHO cells. Immuno-
ﬂuorescence analysis showed that C5aR L318A was expressed on the
cell surface, whereas the C5aR L318A/L319A and the C5aR L319A mu-
tants localized in the perinuclear region with a staining pattern char-
acteristic of the endoplasmic reticulum (ER) (Fig. 1A).
Previous studies have shown that certain conformational changes
in transmembrane proteins lead to ER retention [15]. The localization
of N-glycosylated proteins in the ER can be veriﬁed by removal of their
characteristic high-mannose glycanswith endoglycosidaseH (EndoH).
Upon entry to Golgi, the proteins become terminally glycosylated and
are no longer Endo H sensitive [16]. We treated crude membranes of
the CHO transfectants with Endo H and detected the receptors by
western blotting. We found that the vast majority of the non-treated
mutant C5aR L319A and C5aR L318A/L319A migrated faster than C5aR
and C5aR L318A in SDS-polyacrylamide gel, indicating different post-
translational modiﬁcations (Fig.1B). Upon Endo H treatment these fast
migratingmutantswere successfully trimmed, further increasing their
mobility. The observed sensitivity of C5aR L319A and C5aR L318A/
L319A to EndoH suggested that the receptors hadnot been transported
beyond ER. In contrast, C5aR and C5aR L318Awere resistant to Endo H
digestion, implying their advanced processing in the Golgi. Therefore,
we conclude that mutation of L319 in the carboxyl tail of C5aR resulted
in ER retention, whereas mutation of the neighboring L318 did not
interfere with trafﬁcking through the secretory pathway.
3.2. Mutant receptor C5aR L318A is characterized by attenuated
internalization
To examine the effect of the L318A mutation on ligand-induced
endocytosis, we carried out immunoﬂuorescence microscopy. We
found that unlike the wild type receptor, a signiﬁcant proportion of
the mutant was retained on the cell surface after a 3 h stimulationFig. 4.Wild type andmutant C5aR L318A showed similar activation of ERK1/2. A) CHO transfe
100 nM C5a for the indicated times. ERK1/2 phosphorylationwas detected in the cell lysates
loading and expression of ERK1/2 by immunoblotting with anti-ERK1/2 antibody. B) CHO tran
ERK1/2 antibody was used to detect phosphorylated ERK1/2. Equal loading was tested by swith 100 nM C5a (Fig. 2A). To better visualize the internalized recep-
tor, we stimulated cells in the presence of ammonium chloride, aweak
base that inhibits ligand dissociation and receptor recycling due to the
reduction of endosome acidiﬁcation [17]. Indeed, inhibition of the
recycling step increased the intracellular retention of C5aR L318A
(Fig. 2) where it colocalized with early endosome antigen protein 1
(data not shown).
To quantitatively analyze the internalization of wild type C5aR and
C5aR L318A, we measured the uptake of 125I-C5a. Stimulation of the
wild type receptor with 100 nM C5a mixed with a trace amount of
125I-C5a resulted in signiﬁcant internalization of C5a (∼60%) within
30 min (Fig. 2B). Internalization of the mutant was less efﬁcient at
every time point, corroborating the results from the immunoﬂuores-
cence microscopy analysis. About 40% of C5awas internalized by C5aR
L318A during 30 min of continuous stimulation, a signiﬁcant differ-
ence compared to the wild type receptor (p b 0.01). Together these
results suggest that L318 is involved in regulating sequestration of the
activated receptor.
Since agonist-dependent phosphorylation of C5aR is a prerequisite
for efﬁcient internalization, and dephosphorylation occurs after
endocytosis [1], we examined the time course of receptor phosphor-
ylation/dephosphorylation. The phosphorylation state of C5aR can be
visualized in pulse–chase experiments as a shift in protein mobility in
western blots [9,18]. Wild type C5aR showed complete receptor
phosphorylation after a 10min incubationwithC5a (0min chase) and a
complete dephosphorylation after a 60 min chase, whereas C5aR
L318A was not fully phosphorylated after the 10 min pulse and
remained largely phosphorylated after the 60 min chase (Fig. 3). This
provided the third piece of evidence that the L318A mutation affects
receptor endocytosis.
3.3. The L318A mutation does not affect the signaling properties of C5aR
Several studies have demonstrated the importance of the mem-
brane-proximal region of GPCR in the interactionwith G protein and for
proper signaling [19–21]. To determine whether the L318A mutation
affects receptor signaling, we analyzed time- and ligand concentration-ctants were pre-incubated overnight with or without 200 ng/ml PTX and activated with
by immunoblotting using anti-phospho-ERK1/2 antibody. Samples were tested for equal
sfectants were exposed for 5 min to the indicated concentrations of C5a. Anti-phospho-
taining the ﬁlters with Ponceau S prior to antibody incubation (data not shown).
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downstream effectors of C5aR activation are extracellular signal-
regulated kinases 1/2 (ERK1/2). CHO cells expressing either wild type
C5aRor themutant receptorwere stimulatedwith 100nMC5a for 0, 2, 5,Fig. 5.Wild type and C5aR L318A mutant induced similar C5a-mediated mobilization of intr
measured in dual wavelength excitation in response to addition of various concentrations of C
on each graph shows the difference between the base line value and the C5a-induced peak v
analysis.10 and 30 min. Activation of ERK1/2 was detected using phospho-
speciﬁc anti-ERK1/2 antibody. Both wild type and mutant receptors
showed maximal ERK1/2 activation at 2 to 5 min of stimulation and
saturation at 2 nM C5a (Fig. 4A and B). Since pre-incubation withacellular Ca2+. CHO transfectants were loaded with Fura 2-AM and calcium release was
5a (added at 50 s).10 μMATPwas added at 100 s as a positive control stimulus. Numbers
alue. EC50 was calculated from three independent experiments by non-linear regression
Fig. 6. Mutation of L318 led to attenuated phosphorylation of C5aR. CHO cells stably
expressing C5aR or C5aR L318A were stimulated with 5 nM C5a for the indicated times.
Dynamics of the S334 phosphorylation were analyzed by western blotting of the total
membranes using anti-phosphoS334-C5aR monoclonal antibody 32-G1 (upper panel).
GRK-mediated phosphorylation was analyzed from the same samples by western
blotting using polyclonal C5aR antibody (lower panel). The graphs show the relative
amounts of phosphorylated C5aR. In the upper graph, the data are expressed as the
percentage of S334 phosphorylation with the strongest signal set at 100%. In the lower
graph, the relative amount of phosphorylated C5aR is shown as the percentage of slow-
migrating C5aR out of total C5aR. Since these densitymeasurements are difﬁcult to carry
out with complete accuracy, the results should not be viewed as absolute, but indicative
of the phosphorylation trend. Each data point represents the mean value±S.D. of three
independent experiments (⁎⁎pb0.01; ⁎⁎⁎pb0.001).
Fig. 7. A) GRK2 translocates to the cell membrane upon activation with C5a. CHO
transfectants were stimulated for 10 min with the indicated amounts of C5a, and GRK2
was detected from membrane fractions by western blotting. One representative image
from three experiments is shown. B) PKCβII and GRK2 bind preferentially to the third
intracellular loop of C5aR in in vitro binding assay. Afﬁnity puriﬁed GST-tagged
cytoplasmic domains of C5aR and the carboxyl tail of C5aR L318A were incubated with
cytosol from activated neutrophils. Eluates were analyzed by immunoblotting with
anti-GRK2, anti-phospho-PKCβII, anti-RhoA, and anti-Arf6 antibody. 2% of the cytosol
versus 25% of the eluate was loaded. Abbreviation: il — intracellular loop, CT — carboxyl
tail.
Fig. 8. Limited proteolysis of C5aR and C5aR L318A in CHO membranes. Triton X-100
solubilized membranes of CHO cells expressing C5aR or C5aR L318A were treated with
trypsin. Samples were analyzed in western blots using anti-C5aR antibody. Images are
representative of three independent experiments. The graph shows relative receptor
degradation during 1 h incubation. Dynamics of the receptor disappearance on the
western blots was analyzed by scanning densitometry using Scion Image software.
Signal from non-treated membranes (0 min) was set at 100%. Each data point is the
mean±S.D. of three independent experiments.
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conﬁrmed that both C5aR and C5aR L318A mainly used Gi to activate
ERK1/2 (Fig. 4A).
Another C5a-initiated pathway results in intracellular Ca2+ release
from the ER [1]. To quantify the EC50 for calcium release, we
stimulated transfected CHO cells with different concentrations of
the ligand. Calculated EC50 values were similar for both receptors,
0.15 nM versus 0.19 nM for C5aR and C5aR L318A, respectively (Fig. 5).
Together these results indicated that the L318 mutation did not affect
Gi-mediated signaling.
3.4. L318A mutation causes a delay in C5aR phosphorylation
To examine whether the apparent reduction in endocytosis of the
C5aR L318A mutant correlates with a reduction in receptor phosphor-
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C5aR: 1) 32-G1, a recently developed and characterized monoclonal
antibody that binds speciﬁcally to C5aR phosphorylated on S334. This
residue has been shown to be rapidly and transiently phosphorylated
by PKC βI/II at subnanomolar to nanomolar concentrations of C5a in
myeloid cells [10]; 2) Rabbit anti-C5aR polyclonal antibody produced
against the 12 C-terminal amino acids of C5aR (also used in Fig. 3)
detects both the nonphosphorylated and phosphorylated receptor. A
visible shift in C5aR is not detectable upon phosphorylation of S334
alone, but requires phosphorylation of multiple residues characteristic
of GRK activity [9,18]. Thus, these two antibodies can be used to follow
receptor phosphorylation by PKC and GRK, respectively.
We compared the kinetics of phosphorylation of the wild type and
L318A receptors using 5 nM C5a. As previously shown inmyeloid cells,
wild type C5aR was phosphorylated on S334 in a time-dependent
manner reaching maximal phosphorylation at 3 min, whereas C5aR
L318A showed less efﬁcient phosphorylation at early time points (1
and 3 min) (Fig. 6). Similarly, western blots of the same samples using
the polyclonal anti-C5aR antibody suggested that GRK-mediated
phosphorylation of C5aR L318A is delayed at 3–10 min compared to
wild type C5aR (Fig. 6).
3.5. GRK2 translocates to the cell membrane in response to C5a
GRK2, 5 and 6 are putative kinases engaged in the homologous
desensitization of C5aR [4]. Because GRK2 is particularly abundant in
peripheral blood leukocytes and myeloid cell lines, we searched the
sequence of the C5aR carboxyl tail for putative GRK2 phosphorylation
sites [5]. The presence of the acidic residues E325, E326 and E331
upstream of S327 and S332, respectively, suggested that these serines
are possible targets for phosphorylation by GRK2 [22]. Unlike GRK4,
and GRK5/6 that are constitutively associated with membranes due to
their lipid modiﬁcation, membrane recruitment of GRK2/3 is entirely
dependent on interaction with uncoupled G protein subunits [2]. This
provides a tool to examine GRK2/3 activation upon receptor stimula-
tion. CHO cells expressing either wild type C5aR or L318Amutantwere
brieﬂy stimulated with different concentrations of C5a. To investigate
themembrane translocation of GRK2, total membranes were analyzed
by western blotting using anti-GRK2 antibody. We found that some
GRK2 was associated with membranes even at steady-state (Fig. 7A).
However, activation of both wild type and mutant receptors with
increasing amounts of C5a resulted in the gradual increase of GRK2 on
the membranes. The results from four independent experiments on
CHO C5aR cells showed a 3.2-fold (±1.3) increase in GRK2 on the
membranes upon exposure to 100 nM C5a; for CHO C5aR L318A cells,
the increase was 2.9-fold (±1.1), suggesting the involvement of GRK2
in agonist-dependent phosphorylation of C5aR.
3.6. The carboxyl tail of C5aR may not be a major domain of physical
interaction with kinases involved in receptor phosphorylation
One of the possible explanations for the slow phosphorylation of
C5aR L318A is that the mutation reduces the binding afﬁnity for
kinases. To determine if L318 is part of a PKC or GRK2 binding domain,
we cloned the putative cytoplasmic domains of C5aR as GST-tagged
proteins. Recombinant proteins, GST-intracellular loop 1 (GST-il1), -il2,
-il3, -cytoplasmic tail (-CT), CT L318A and GST alone, were tested for
their capacity to bind cytosolic proteins from activated neutrophils.
While no signiﬁcant binding was detected in the control mixture (GST
alone), we found a relatively strong interaction of C5aR il3 with GRK2
and PKCβII (Fig. 7B). However, the carboxyl tails of wild type and
mutant receptors showed a similar, but weaker interaction with
kinases. This indicated that the C-tail of C5aR may not be a major
binding domain for GRK or PKC, although we cannot exclude the
possibility that these kinases may show different binding preferences
to the native C5aR. Our result coincides with previous reportsimplicating a role for several basic residues in the second and third
intracellular loops of GPCRs in GRK activation [23–25]. The putative
third intracellular loop of C5aR contains four arginines that could
potentially participate in the interaction.
3.7. L318A mutation affects the tryptic cleavage of C5aR suggesting a
structural change in the mutant
Since the cytoplasmic tail of C5aRmay not be involved in binding of
GRK2 and PKCβII, we hypothesized that the L318Amutationmayaffect
receptor phosphorylation by introducing changes in the receptor
conformation. The putative hydrophobic folding motif HXXXHXXHH
(H represents a hydrophobic residue, and X is any amino acid residue)
was recently identiﬁed in the carboxyl tail of several GPCRs [26].
Studies with mutants revealed that the stretch of amino acid residues
(VSSELRSLL) in themembrane-proximal region of vasopressin 2 recep-
tor (V2R) does not function as a linear transport signal, but rather is
required for competent folding of the receptor [27]. C5aR contains a
sequence resembling the described folding motif (311LRKSLPSLL319)
located a short distance from the 7th transmembrane domain. If this
sequence functions as a folding motif for C5aR, the L318A and L319A
mutationswould cause changes in the receptor structure. The fact that
C5aR L319A and C5aR L318A/L319A mutants were retained in the ER
favors our hypothesis, because an improper folding has been suggested
to be themain reason for protein retention in the ER [28]. To determine
whether there are differences in the folding of the wild type receptor
and the L318Amutant, we compared their relative susceptibility to the
protease trypsin. Membranes of CHO cells expressing either C5aR or
C5aR L318A were solubilized in Triton X-100 and treated with diluted
trypsin. Digestion efﬁciency was estimated by western blotting using
polyclonal anti-C5aR antibody. Fig. 8 shows the disappearance of the
receptor band during a 1 h incubation. After 10 min of treatment, 90%
of C5aR, but only 60% of themutantwas digested by trypsin. Therefore,
wild type C5aR was relatively more susceptible to digestion than the
mutant, implying a difference in receptor folding.
4. Discussion
Proteins containing mutations that cause structural and functional
changes are frequently recognized and retained by the quality control-
system in the ER. Various retention signals have been characterized
such as an arginine-based ER-retentionmotif that becomes exposed in
a deletion mutant of cystic ﬁbrosis transmembrane conductance re-
gulator (CFTR) [28,29]. We found a correctly situated Arg-rich se-
quence in the cytoplasmic tail of C5aR that matches an ER-retention
signal (308QGRLRKS314). An attempt by Matsumoto and co-workers to
express selected C5aR cytosolic tail mutants created by random sa-
turation mutagenesis in HEK293 or COS7 cells failed due to receptor
retention in the ER [30]. Interestingly, analysis of these and other C5aR
cytoplasmic tail mutants in yeast identiﬁed R310 as a “preserved”
critical residue in the ﬁrst half of the C5aR C-tail, favoring our as-
sumption that the 308QGRLRKS314 sequence could function as an ER-
retention signal for C5aR [31]. While masked in the properly folded
C5aR, this stretch of residues could become exposed in certain mu-
tants with altered conformation. This is a possibility for the C5aR
L319A and C5aR L318A/L319A mutants which were shown to be
retained in the ER of CHO cells.
The crystal structure of rhodopsin indicated a short amphipathic
helix, helix 8, in the membrane-proximal region of the C-tail [32]. This
ﬁnding was recently conﬁrmed from the crystal structure of another
GPCR, the β2-adrenergic receptor [33]. Similar structures have been
identiﬁed inmanyotherGPCRs, either bycomputermodelingor peptide
structure analysis [19–21,34,35]. Sequence alignment of C5aR and
rhodopsin revealed a similar pattern of alteration of hydrophobic and
hydrophilic residues, suggesting the presence of a similar helix in the
carboxyl tail of C5aR (Fig. 9A). From the rhodopsin structure, it appears
Fig. 9. A structural model of the membrane-proximal domain of C5aR. A) Sequence alignment of the putative helix 8 of bovine rhodopsin and human C5aR. PSIPRED prediction
numbers represent the conﬁdence rate for a helical secondary structure (0=low, 9=high). Dashed line underlines a cytoplasmic helix predicted by PSIPRED (http://bioinf.cs.ucl.ac.uk/
psipred/). Color code: red— small and hydrophobic residues, magenta— basic residues, blue — acidic, green— hydroxyl, amine, basic residues and glutamine. B) Side view (left) and
projection across the extended amphipathic helix 8 (right) of C5aR. C) Mutation of di-leucine L318/L319 to alanines signiﬁcantly reduces the hydrophobicity around the COOH-
terminus of the helix. Left and right panels show the hydrophobic and hydrophilic surfaces, respectively, of the C5aR (upper panel) and C5aR L318A/L319A (lower panel) helix. Leucine
to alanine mutation is shown in yellow.
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induce an α-helical structure. Helix 8 of rhodopsin ends at the
membrane insertion of the palmitoyl groups attached to C322 and
C323. The majority of GPCRs that belong to class A of rhodopsin-like
family receptors also have single or multiple cysteines in the cor-
responding area of the cytoplasmic tail. Other GPCRs, such as receptors
for angiotensin, fMLF, chemokines, somatostatin and C5a, have a helix-
breaking proline instead of cysteines at the end of the putative helix.
However, proline does not always behave as a strong helix breaker. Five
out of seven C5aR transmembrane helices have prolines that introduce a
kink in the helix. CD spectra of model amphipathic peptides revealed
that the central proline kept α-helical structures in membrane-mimetic
environments and broke an α-helix in aquatic buffer [36].We suggested
an alternative folding of themembrane-proximal region of C5aR, where
P316 does not break, but rather induces a kink in the prolonged
amphipathic α-helix (Fig. 9B). Our suggestion is based on the continued
regular occurrence of hydrophobic amino acids after P316. The bulky
hydrophobic side chain of L318 and L319 extend a hydrophobic patch
and, thereby, may support an α-helical structure of the amphipathic
helix. In ourmodel, the kink induced by P316 brings the bulky side chain
of L319 closer to P316, which could be crucial for proper folding and/or
stabilization of the structure. Ourprediction coincideswith the results of
the PSIPRED computational analysis of C5aR (http://bioinf.cs.ucl.ac.uk/
psipred/) that placed the P316 in the cytoplasmic helix with the highest
possible conﬁdence rate of 9 [37].
It is unlikely that the exchange of L318 and/or L319 to alaninewould
affect the helicity of the structure in our mutant receptors because
hydrogen bonding within the main chain is unchanged. Instead, a
major effect comes from the loss of the bulky hydrophobic side chains
(Fig. 9C). P316 would be more exposed to solvent, which may result in
either a more pronounced kink or even a disordered helix. Indeed, the
conformation of C5aR L319A is presumably signiﬁcantly altered since
that mutant is retained in the ER. The L318A mutation caused a less
dramatic, but detectable structural change basedon limitedproteolysis
with trypsin. Thus the leucine residues with their bulky side chains
appear to play an important role in stabilizing the α-helix in the
cytoplasmic tail of C5aR.
Other data that support the prolonged α-helix were obtained from
recent structure–function mapping of C5aR in a yeast model system.
Screening of themutants obtained byRSM identiﬁed fewresidueswith
a preserved hydrophobicity in the ﬁrst half of the C5aR carboxyl tail
[31]. L311, L315, and L318 (L319 was excluded from the screen)
tolerated only conservative substitutions, emphasizing the importance
of elongation of the hydrophobic surface after P316 in the predicted
amphipathic helix. On the other hand, previously reported mutations
of the polar residues S314 and S317 located in the same area did not
affect export of C5aR to the cell surface, implicating a hydrophilic face
of the helix in functions other than receptor folding [38].
We hypothesized that the loss of bulky hydrophobic side chains of
leucines at the COOH-terminus of helix 8 led to conformational changes
in C5aR. To test this, we used limited proteolysis to study protein
conformation and structural alterations based on cleavage of the folded
polypeptide chain at theexposedﬂexible regions [39]. As expected, C5aR
and the L318A mutant exhibited different relative susceptibility to
trypsin: C5aR L318Awasmore resistant to proteolysis than thewild type
receptor (Fig. 8). This ﬁnding together with the observed ER retention of
the L319A mutant supported our idea of the involvement of these
hydrophobic residues in C5aR folding.
Interactionwith G protein and control of receptor signaling are the
most prominent roles of GPCRs' helix 8. Mutation of the basic residues
in helix 8 of certain GPCRs including rhodopsin,β1-adrenergic receptor
(β1-AR), and rat melanin-concentrating hormone receptor 1 affected
their coupling to cognate G proteins [19–21]. The hydrophobic surface
of helix 8 of C5aR may not be involved in interaction with G proteins,
since no signiﬁcant changes in intracellular signaling by the mutant
receptor were detected (Figs. 4 and 5). Bulky hydrophobic side chainsmay be required for membrane attachment of the carboxyl tail,
orienting the polar side chains toward the cytoplasm. A similar
orientation was predicted for an amphipathic helix of the proteins
involved in intracellular trafﬁcking [40]. Insertion of the hydrophobic
face of the α-helix into the lipid bilayer is thought to increase the
positive membrane curvature, which is essential for initiation of
membrane vesicle budding. It is tempting to suggest that a similar
orientation of C5aR helix 8 would facilitate receptor internalization,
considering that certain GPCRs including C5aR are sequestered during
desensitization. Nevertheless, another possible orientation of the helix
should also be considered where positively charged side chains in-
teract with negatively charged lipid head groups, leaving the hy-
drophobic surface of the helix for protein–protein interactions.
A growing body of evidence strengthens the role of helix 8 in
internalization of agonist-activated GPCRs. Mutation of hydrophobic
residues of the cytoplasmic helix of angiotensin II receptor and a bra-
dykinin receptor chimera led to attenuated and/or inefﬁcient endocy-
tosis [34,35]. Similarly,wedemonstrated that themutationof L318 in the
C5aR carboxyl tail resulted in attenuation of agonist-dependent
internalization. Detailed analysis of the C5aR L318A mutant revealed
one of the reasons for the slow internalization of the receptor. Dis-
turbance of the hydrophobic surface of the putative cytoplasmic helix of
C5aR led to defects in receptor phosphorylation by both PKC and GRK,
which, in turn, affected receptor sequestration. This conclusion is based
on the combination of our experimental data and previously published
evidence of severely impaired internalization of certainphosphorylation
deﬁcient mutants of C5aR [10,18,41]. In addition, a direct connection
between phosphorylation and internalizationmachineries was recently
discovered through identiﬁcation of the clathrin binding domain in the
carboxyl terminal region of GRK2. The functionality of the domain was
veriﬁed by inhibition of the β2-AR phosphorylation in cells over-
expressing GRK2 using the siRNA for the clathrin heavy chain [42].
The speciﬁc interaction betweenGPCRs and kinases remains poorly
characterized.We detected translocation of GRK2 to themembranes of
C5a-activated CHO cells expressing either C5aR or C5aR L318A, which
implicated this particular GRK in C5aR phosphorylation (Fig. 7A).
Experimental evidence suggested that ionic interactions between
basic residues of GPCR and negatively charged amino acids of GRK2
regulate kinase binding to receptor [2,23,25]. Similar to α2A AR and
metabotropic glutamate receptor 1 (mGluR1), the third intracellular
loop of C5aR showed interactionwith GRK2 in our GST pull down assay
(Fig. 7B). Previous mapping of PKC-mediated phosphorylation sites of
C5aR restricted them to serines in the carboxyl tail [43]. We found a
preferential binding of PKCβII to the third loop of C5aR which is in
agreement with the idea of distinct domains for PKC binding versus
phosphorylation [44]. It has been suggested that the binding site
situates the kinase into the most favorable position for phosphoryla-
tion. Similar to GRK, the ionic interaction involving basic residues in
the membrane-proximal region of glutamate receptors participated in
the binding of PKC [44,45]. C5aR has the polybasic sequence
(229RTWSRR234) in the third cytoplasmic loop that resembles the
PKCγ binding sites of GluR1 (RSESKR) and GluR4 (RAEAKR) and, thus,
may regulate a sequential binding of PKC and GRK.
In summary, this study demonstrated that the bulky hydrophobic
amino acid residues L318 and L319 in the membrane-proximal region
of the C5aR carboxyl tail play an important role in receptor structure
and function. Mutation of leucine 319 to alanine caused retention of
the receptor in the ER, presumably due to misfolding. Mutation of
leucine 318 to alanine resulted in reduced receptor phosphorylation
and endocytosis, apparently due to a structural change, as evidenced
by differential sensitivity to tryptic cleavage.
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